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In this issue of Immunity, Feyerabend et al. (2009) report that Delta-like 4, acting on Notch 1, prevents pro-T
cells from differentiating into dendritic cells and B cells. In addition, in the absence of Notch 1, B cells in the
thymus arose from a cell-extrinsic pathway.For some years we have been aware of the
role of Notch signaling in T cell lineage
commitment. The common tenor of early
studies is that interference with Notch
signaling in early hemopoietic or T cell
development results in abolition of the
T cell lineage and vastly increased
numbers of thymic B cells by unknown
mechanisms. In this issue of Immunity,
Feyerabend et al. (2009) report on a
powerful approach that combines condi-
tional Notch 1 ablation in pro-T cells with
lineage fate mapping to conclude that
Delta-like 4 (Dll4)-induced Notch signaling
is required to keep pro-T cells on track to
differentiate into T cells, preventing their
diversion into dendritic cells (DCs) and
B cells. Interestingly, Notch1 deficiency in
pro-T cells results in accumulation of
thymic B cells by cell-intrinsic as well
as -extrinsic mechanisms.
In lineage fate-mapping studies, Feyer-
abend et al. (2009) employed knockin
mice, in which the cre-recombinase was
expressed under control of the promoter
of the Cpa3 gene (Reynolds et al., 1989)
that encodes the mast cell carboxypepti-
dase a (Mc-cpa). The recombinase could
then activate a red fluorescent protein
(RFP) reporter by elimination of a floxed
stop cassette, thereby tracking the ex-
pression of Cpa3. The reporter was ex-
pressed in about 90% of T cells but only
marginally in B cells. Like other mast
cell-specific genes, Cpa3 is expressed inpro-T but not mature T cells (Taghon
et al., 2007), providing a rational explana-
tion for the fate-mapping results. Closer
inspection revealed that about 25% of
the most immature c-Kit+ Flt3+ and about
45% of c-Kit+ thymic pro-T cells were
RFP+ increasing up to 90% in DN2 thymo-
cytes, consistent with the view that the
reporter came on in the earliest thymic
pro-T cells after B cell potential was extin-
guished. This enabled the authors to
conduct elegant studies by conditional
ablation of Notch 1 combined with fate
mapping to study the role of Notch 1 in T
lineage fate.
The lineage fate-mapping studies docu-
ment that under physiological conditions,
pro-T cells (at least the ones that express
Mc-cpa) do not ‘‘spin off’’ DCs because
DCs of all subsets, i.e., lymphoid, myeloid,
or plasmacytoid, whether from spleen or
thymus, exhibited similar frequencies of
RFP+ cells, which were lower than among
c-Kit+ pro-T cells. Had the thymic DCs
been derived from Mc-cpa-expressing
pro-T cells, their frequency of RFP+ cells
should have been much higher than that
among peripheral DCs. However, under
nonphysiological conditions, pro-T cells
can differentiate into DCs in vitro (Bell
and Bandhoola, 2008) Thus, intrathymic
DCs may normally be derived from very
early Mc-cpa-negative thymic pro-T cells
or from precursors unrelated to the T cell
lineage. Because the normal thymusImmunitycontains very few B cells, their origin is of
lesser physiological relevance.
The fate-mapping results change dras-
tically when Notch 1 is deleted in pro-
T cells. Under these conditions, the
proportion of RFP-expressing DCs of all
subsets increased inside but not outside
the thymus, indicating that this increase
was due to pro-T cell-derived DCs. More-
over, the number of thymic B cells
increased drastically but the majority of
B cells did not appear to be derived from
Notch1-deficient pro-T cells because
most CD19hi B cells had not deleted their
Notch1 alleles as detected by single-cell
PCR. In contrast to this newly recognized
cell-extrinsic pathway, Notch1 was quan-
titatively deleted in the majority of CD19lo
B cells. Consistent with this notion, RFP-
labeling frequencies were also higher in
CD19lo B cells than in CD19hi B cells
(Figure 1). These data were not shown
because RFP-labeling frequencies did
not reach the frequencies observed for
Notch1 deletion, indicating that Mc-cpa-
Cre acted more efficiently on the floxed
Notch1 allele than on the floxed RFP allele
in the ROSA locus. The authors therefore
considered the Notch1 genotype as the
most direct molecular evidence for fate
conversion of Notch1-deleted pro-T cells
to thymic B cells. Only a minor subset of
CD19lo B cells exhibits deletion of both
Notch 1 alleles and hence drives their
conversion from the pro-T cell lineage.30, January 16, 2009 ª2009 Elsevier Inc. 5
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PreviewsSuch conversion has been suspected
for some time but has been difficult to
demonstrate directly. Much of the
increase in numbers of thymic B cells
was due to an increase by a cell-extrinsic
mechanisms resulting from Notch 1 dele-
tion in pre-T cells, a result that could not
be anticipated from earlier studies on the
role of Notch1 in lineage commitment.
This surprising result is supported by the
observation that only the thymic CD19lo,
but neither the thymic CD19hi nor the
peripheral CD19lo or CD19hi B cells,
contain Db1 to Jb1 rearrangements of the
TCRb locus. This is also true for some of
the pro-T cell-derived DCs that have
much higher frequencies of deletion of
both Notch1 alleles when compared to
splenic DCs. Furthermore, the lymphoid
and plasmacytoid but not the myeloid
DCs exhibit the same rearrangement of
the TCRb locus as found in pro-T cell-
derived B cells. This then indicates that
Notch signaling is required to keep pro-
T cells on track to generate pre-T cells
and to prevent them from generating
non-T lineage cells such as DCs and
B cells. Regarding the accumulation of
thymic B cells that were not derived
from Notch1-deleted pro-T cells, the
authors offer two scenarios that could
account for these observations: B cells
may accumulate either because aborted
T cell development generates space that
can be filled by mature B cells or because
the absence of Dll4 ligation by the Notch 1
receptor ‘‘conditions’’ the thymus via an
epithelial cell-dependent mechanism to
accumulate B cells derived from unknown
precursors. Clearly, more work is required
to explain this unexpected finding.
The authors also provided compelling
evidence that Dll4 rather than Dll1 ligands
on thymic epithelium are essential to
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Figure 1. The Role of Notch Signaling in Pro-T Cells
In T cell development, Notch1 signaling in pro-T cells prevents them from differentiating into DCs and
B cells (top). In contrast, Notch-deficient pro-T cells abort T cell development and generate DCs and
thymic B cells that have deleted both Notch alleles and exhibit DJ rearrangements of the TCRb locus
(Db1Jb1). In addition, B cells are generated that do not derive from Notch-deficient pro-T cells by an
as-yet-unknown mechanism (bottom).6 Immunity 30, January 16, 2009 ª2009 Elsevier Inc.induce Notch signaling in pre-T cells. By
injecting Dll1- or DLll4-deficient embry-
onic stem (ES) cells into Foxn1/ blasto-
cysts to produce Dll1- or Dll4-deficient
thymic epithelium (Rodewald, 2008),
Feyerabend etal. (2009) report a functional
chimeric thymus in the case of Dll-1-defi-
cient ES cells, arguing that Dll-1 is
dispensable for T cell development (and
expressed mostly in blood vessels rather
than epithelial cells) whereas in the case
of Dll4-deficient ES cells the resulting
chimeric thymus exhibits a three-dimen-
sional structure that is mature compared
to the Foxn1/ thymus and contains
Dll-4-deficient ES cell-derived epithelial
cells but this chimeric thymus did not
support T cell development. The finding
that T cell development fully depends on
Dll4-expressing thymic epithelium is in
keeping with Dll4 deletion in this tissue
with Cre technology (Koch et al., 2008;
Hozumi et al., 2008). Hence, the conclu-
sion is that Dll4 is essential and that
in situ, Dll1, often used to study T cell
development in vitro, has no role in T cell
development.
This study provides a perfect example of
how a combination of genetic approaches
that include lineage fate mapping, condi-
tional gene ablation, and blastocyst
complementation can provide conclusive
answers to questions concerning the role
of Notch-ligand-induced signaling and
thereby regulation of transcription by intra-
cellular Notch at defined stages of lympho-
cyte development. Although it is clear that
earlier studies showed an essential role of
Notch1 in T lineage fate determination
and generated some ideas of how Notch1
could influence lineage fate, the conclu-
sive analysis of this report not only
confirmed some preconceived ideas but
in addition came up with new surprises
that warrant further explanation.
Presently, we have information about
the role of Notch1 in lineage fate determi-
nation of pro-T cells (Feyerabend et al.,
2009) and in pre-T cells where Notch syn-
ergizes with the pre-TCR to generate ab
T cell lineage cells (Ciofani et al., 2006;
Garbe et al., 2006). Although we now
better understand some principles of how
Notch1 influences lineage fate at distinct
checkpoints in T cell development, the
task remains to figure out the molecular
pathways that are involved. To this end,
it is a great advantage that now in addition
to Lck-Cre we have Mc-cpa-Cre that
Immunity
Previewscomes on in pro-T cells and will enable the
deletion of Notch1 target genes in pro-T
cells to assess their role in Notch1-
induced lineage fate.
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lineages and find that commitment
Early studies described CD4+ T cell
effector lineage commitment as a unidirec-
tional process leading to the stable expres-
sion of one of two mutually exclusive cy-
tokine profiles by Th1 and Th2 cells.
However, the description of additional
helper T cell fates has complicated this
model, and in vivo observations of cells
with mixed phenotypes have raised ques-
tions about the stability of helper lineage
fidelity and the relationships among line-
ages. For example: naive CD4+ T cells
differentiate in vitro into Th1 and Th17
effectors that produce IFN-g and IL-17 in
a mutually exclusive manner (at least in
the mouse), but these two cytokines are
often coexpressed in vivo in the context
of infectious or autoimmune diseases
(McGeachy and Cua, 2008); Th17 cells
can express the regulatory T cell-speci-
fying transcription factor Foxp3, whereas
regulatory T cells can be induced to
produce IL-17 (Xu et al., 2007; Yang et al.,
2008); and regulatory T cells can be di-
verted toa Th2 cell lineage if Foxp3 expres-
sion is suppressed (Wan and Flavell, 2007).
Approaching the question of lineage
fidelity from two very different angles, the
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(2009) and Wei et al. (2009) each inve
to these fates is more plastic than pr
(2009) demonstrate that T helper cell
lineages retain a surprising degree of
plasticity, which may allow them to adopt
alternative fates or to acquire functions
normally restricted to an opposing CD4+
T cell lineage.
Transcription factors can directly acti-
vate or repress gene expression and
can induce modifications to chromatin
and methylation of DNA at regions where
they bind. These epigenetic modifica-
tions in turn influence the ease with which
transcription factors can bind to their
cognate regulatory sequences and (along
with differences in transcription factor
availability) determine when and to what
extent specific genes are expressed in
a particular cell. Epigenetic modifications
can be inherited through successive cell
divisions, but unlike alterations to the
underlying DNA sequence, they are also
subject to revision in response to
changes in environmental cues. There is
considerable support for the notion that
epigenetic modifications contribute to
the heritability of T helper cell lineage
choice, while implicitly providing the
option for this choice to be subsequently
revised.
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With this premise in mind, Wei et al.
(2009) set out to explore lineage relation-
ships, commitment, and potential for plas-
ticity in T helper cells. To do so, they used
ChIP-Seq (a technique they helped to
pioneer) to generate complete, compara-
tive genome-wide maps of two informative
and complementary histone modifications
in naive, Th1, Th2, Th17, and induced
(iTreg) and natural regulatory (nTreg)
CD4+ T cells. Trimethylation of lysine 4 on
histone H3 (H3K4me3) is a permissive
mark found at active or poised promoters,
whereas trimethylation of lysine 27 on
histone H3 (H3K27me3) is a mark of
Polycomb-mediated gene silencing. As
expected, enrichment for H3K4me3 corre-
lated perfectly with lineage-appropriate
expression of the genes encoding the cy-
tokines IFN-g, IL-4, IL-17A, and IL-17F
and the transcription factors ROR(g)t and
Foxp3, which help to instruct Th17 and
Treg cell lineage choice, respectively
(Figure 1). However, there was consider-
able heterogeneity as to whether cytokine
or transcription factor genes whose
expression is specific for one effector
lineage were marked by repressive
H3K27me3 in opposing lineages. This
30, January 16, 2009 ª2009 Elsevier Inc. 7
